CAD 0.5
(25.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 20 Thousand CAD | 0.0% |
2022 | - CAD | 0.0% |
2021 | - CAD | -100.0% |
2020 | 140.71 Thousand CAD | 27.16% |
2019 | 110.65 Thousand CAD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 20 Thousand CAD | 7.55% |
2024 Q1 | 20 Thousand CAD | 0.0% |
2023 Q3 | - CAD | 0.0% |
2023 FY | 20 Thousand CAD | 0.0% |
2023 Q4 | 20 Thousand CAD | 0.0% |
2023 Q2 | - CAD | 0.0% |
2023 Q1 | - CAD | 0.0% |
2022 Q1 | - CAD | 0.0% |
2022 Q3 | - CAD | 0.0% |
2022 Q2 | - CAD | 0.0% |
2022 FY | - CAD | 0.0% |
2022 Q4 | - CAD | 0.0% |
2021 FY | - CAD | -100.0% |
2021 Q4 | - CAD | -100.0% |
2021 Q3 | 2.82 Million CAD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | - CAD | -Infinity% |
BetterLife Pharma Inc. | 245.23 Thousand CAD | 91.845% |
BioVaxys Technology Corp. | - CAD | -Infinity% |
ChitogenX Inc. | 3.87 Million CAD | 99.484% |
Rapid Dose Therapeutics Corp. | 2.45 Million CAD | 99.185% |
Defence Therapeutics Inc. | 1.74 Million CAD | 98.855% |
Entheon Biomedical Corp. | - CAD | -Infinity% |
Gemina Laboratories Ltd. | 285.32 Thousand CAD | 92.99% |
Glow Lifetech Corp. | 116.18 Thousand CAD | 82.786% |
Lexston Life Sciences Corp. | - CAD | -Infinity% |
Pharmala Biotech Holdings Inc. | 253.53 Thousand CAD | 92.112% |
Doseology Sciences Inc. | - CAD | -Infinity% |
MYND Life Sciences Inc. | 3 Million CAD | 99.333% |
Nova Mentis Life Science Corp. | - CAD | -Infinity% |
PharmaTher Holdings Ltd. | - CAD | -Infinity% |
PreveCeutical Medical Inc. | 3.83 Million CAD | 99.478% |
Telescope Innovations Corp. | - CAD | -Infinity% |